Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2022

Open Access 01-12-2022 | osteosarcoma | Case report

Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis

Authors: Chuanxi Zheng, Yitian Wang, Yi Luo, Zongguo Pang, Yong Zhou, Li Min, Chongqi Tu

Published in: BMC Musculoskeletal Disorders | Issue 1/2022

Login to get access

Abstract

Background

Osteosarcoma is the most common primary malignant bone tumor with a highly metastatic propensity in children and young adolescents. The majority of metastases develope in the lung, while metastases to the extrapulmonary locations have rarely been discussed, especially in skeletal muscle.

Case presentation

We reported a young patient with pathologically diagnosed osteosarcoma of the right tibia who was initially treated with standard chemotherapy and complete surgical resection. However, pulmonary metastases and multiple soft tissue masses in skeletal muscle developed four years after the index surgical resection. Subsequently, a targeted next-generation sequencing assay based on an 806 oncogenes and tumor suppressor genes panel was performed to analyze genetic alterations in this patient with rare metastatic pattern. The genetic analysis revealed canonical somatic mutations of RB1 and germline variants of ALK (c.862 T > C), BLM (c.1021C > T), PTCH1 (c.152_154del), MSH2 (c.14C > A), RAD51C (c.635G > A). Using silico prediction programs, the germline variants of the MSH2 and RAD51C were predicted as “Possibly Damaging” by Polymorphism Phenotyping v2 (PolyPhen-2) and “Tolerated” by Sorting Intolerant from Tolerant (SIFT); BLM was classified as “Tolerated”, while the germline variant of ALK was predicted to be pathogenic by both PolyPhen-2 and SIFT.

Conclusions

Osteosarcoma with extrapulmonary metastases is rare, especially located in the skeletal muscle, which predicts a worse clinical outcome compared with lung-only metastases. The several novel variants of ALK, BLM, PTCH1 in this patient might expand the mutational spectrums of the osteosarcoma. All the results may contribute to a better understanding of the clinical course and genetic characteristics of osteosarcoma patients with metastasis.
Literature
1.
go back to reference Kager L, Tamamyan G, Bielack SJFO. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncology. 2017;13(4):357–68.CrossRef Kager L, Tamamyan G, Bielack SJFO. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncology. 2017;13(4):357–68.CrossRef
2.
go back to reference Isakoff MS, Bielack SS, Paul M. Richard GJJoCOOJotASoCO: Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. 2015;33(27):3029–35. Isakoff MS, Bielack SS, Paul M. Richard GJJoCOOJotASoCO: Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. 2015;33(27):3029–35.
3.
go back to reference Ritter J, Bielack SSJAoO: Osteosarcoma. 2010, 21 Suppl 7(suppl_7):vii320–325. Ritter J, Bielack SSJAoO: Osteosarcoma. 2010, 21 Suppl 7(suppl_7):vii320–325.
4.
go back to reference Beate KB, Bielack SS, Heribert J, Detlev B, Berdel WE. G Ulrich E, Ulrich GB, Knut H, Gernot J. Hartmut KJJoCO: Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). 2005;23(3):559–68. Beate KB, Bielack SS, Heribert J, Detlev B, Berdel WE. G Ulrich E, Ulrich GB, Knut H, Gernot J. Hartmut KJJoCO: Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). 2005;23(3):559–68.
5.
go back to reference Bielack SS, Beate KB, Detlev B, Dorothe C, Godehard F, Knut H, Matthias K, Gernot J, Thomas K, Rainer MJJoCOOJotASoCO: Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. 2009, 27(4):557–565. Bielack SS, Beate KB, Detlev B, Dorothe C, Godehard F, Knut H, Matthias K, Gernot J, Thomas K, Rainer MJJoCOOJotASoCO: Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. 2009, 27(4):557–565.
6.
go back to reference Aljubran AH, Griffin A, Pintilie M, Blackstein M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Annals of oncology : official journal of the European Society for Medical Oncology. 2009;20(6):1136–41.CrossRef Aljubran AH, Griffin A, Pintilie M, Blackstein M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Annals of oncology : official journal of the European Society for Medical Oncology. 2009;20(6):1136–41.CrossRef
7.
go back to reference Bielack SS, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, Kevric M, Jundt G, Kuhne T, Maas RJJoCOOJotASoCO: Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients. 27(4):557–565. Bielack SS, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, Kevric M, Jundt G, Kuhne T, Maas RJJoCOOJotASoCO: Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients. 27(4):557–565.
8.
go back to reference Sakamoto Y, Yokouchi M, Nagano S, Shimada H, Nakamura S, Setoguchi T, Kawamura I, Ishidou Y, Tanimoto A, Komiya S. Metastasis of osteosarcoma to the trapezius muscle: a case report. World J Surg Oncol. 2014;12:176.CrossRef Sakamoto Y, Yokouchi M, Nagano S, Shimada H, Nakamura S, Setoguchi T, Kawamura I, Ishidou Y, Tanimoto A, Komiya S. Metastasis of osteosarcoma to the trapezius muscle: a case report. World J Surg Oncol. 2014;12:176.CrossRef
9.
go back to reference Pirayesh E, Rakhshan A, Amoui M, Rakhsha A, Poor AS, Assadi M. Metastasis of femoral osteosarcoma to the abdominal wall detected on 99m Tc-MDP skeletal scintigraphy. Ann Nucl Med. 2013;27(5):478–80.CrossRef Pirayesh E, Rakhshan A, Amoui M, Rakhsha A, Poor AS, Assadi M. Metastasis of femoral osteosarcoma to the abdominal wall detected on 99m Tc-MDP skeletal scintigraphy. Ann Nucl Med. 2013;27(5):478–80.CrossRef
10.
go back to reference Onoro G, Hernandez C, Sirvent S, Aleo E, Molina B, Atienza AL, Perez-Martinez A. Unusual sites of extrapulmonary metastases of osteosarcoma after several lines of treatment. Pediatr Hematol Oncol. 2011;28(7):604–8.CrossRef Onoro G, Hernandez C, Sirvent S, Aleo E, Molina B, Atienza AL, Perez-Martinez A. Unusual sites of extrapulmonary metastases of osteosarcoma after several lines of treatment. Pediatr Hematol Oncol. 2011;28(7):604–8.CrossRef
11.
go back to reference Chan RS, Kumar G, Vijayananthan AA. Rare occurrence of bilateral breast and peritoneal metastases from osteogenic sarcoma. Singapore Med J. 2013;54(3):e68-71.CrossRef Chan RS, Kumar G, Vijayananthan AA. Rare occurrence of bilateral breast and peritoneal metastases from osteogenic sarcoma. Singapore Med J. 2013;54(3):e68-71.CrossRef
12.
go back to reference Strong VE, Shalkow J, Antonescu CR, Meyers P, La Quaglia MP. Osteosarcoma with delayed metastasis to the stomach. J Pediatr Surg. 2007;42(4):737–9.CrossRef Strong VE, Shalkow J, Antonescu CR, Meyers P, La Quaglia MP. Osteosarcoma with delayed metastasis to the stomach. J Pediatr Surg. 2007;42(4):737–9.CrossRef
13.
go back to reference Aarvold A, Bann S, Giblin V, Wotherspoon A, Mudan SS. Osteosarcoma metastasising to the duodenum and pancreas. J Bone Joint Surg Br. 2007;89(4):542–4.CrossRef Aarvold A, Bann S, Giblin V, Wotherspoon A, Mudan SS. Osteosarcoma metastasising to the duodenum and pancreas. J Bone Joint Surg Br. 2007;89(4):542–4.CrossRef
14.
go back to reference Radhakrishnan VS, Balaji J, Lakshminarasimhan S, Karkuzhali P, Vijayasarathy K. Unusual case of extrapulmonary metastatic recurrence in a patient with osteosarcoma. J Clin Oncol. 2011;29(1):e3-5.CrossRef Radhakrishnan VS, Balaji J, Lakshminarasimhan S, Karkuzhali P, Vijayasarathy K. Unusual case of extrapulmonary metastatic recurrence in a patient with osteosarcoma. J Clin Oncol. 2011;29(1):e3-5.CrossRef
15.
go back to reference Ting M, Rodriguez M, Gowda ST, Anders M, Qureshi AM, Grimes A. Cardiovascular recurrence of high-grade osteosarcoma presenting as atrial thrombosis and pulmonary embolism: A case report and review of the pediatric literature. Pediatr Hematol Oncol. 2019;36(4):244–51.CrossRef Ting M, Rodriguez M, Gowda ST, Anders M, Qureshi AM, Grimes A. Cardiovascular recurrence of high-grade osteosarcoma presenting as atrial thrombosis and pulmonary embolism: A case report and review of the pediatric literature. Pediatr Hematol Oncol. 2019;36(4):244–51.CrossRef
16.
go back to reference Kim W, Han I, Lee JS, Cho HS, Park JW, Kim HS. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients. J Surg Oncol. 2018;117(6):1223–31.CrossRef Kim W, Han I, Lee JS, Cho HS, Park JW, Kim HS. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients. J Surg Oncol. 2018;117(6):1223–31.CrossRef
17.
go back to reference Sammon J, Jain A, Bleakney R, Mohankumar R. Magnetic resonance imaging appearance of soft-tissue metastases: our experience at an orthopedic oncology center. Skeletal Radiol. 2017;46(4):513–21.CrossRef Sammon J, Jain A, Bleakney R, Mohankumar R. Magnetic resonance imaging appearance of soft-tissue metastases: our experience at an orthopedic oncology center. Skeletal Radiol. 2017;46(4):513–21.CrossRef
18.
go back to reference Giuliano AE, Feig S, Eilber FR. Changing metastatic patterns of osteosarcoma. Cancer. 1984;54(10):2160–4.CrossRef Giuliano AE, Feig S, Eilber FR. Changing metastatic patterns of osteosarcoma. Cancer. 1984;54(10):2160–4.CrossRef
19.
go back to reference Damron TA, Morganti C, Yang Y, Hojnowski L, Cherny R. Metastasis of osteosarcoma to soft tissue. A case report. J Bone Joint Surg Am. 2000;82(11):1634–8.CrossRef Damron TA, Morganti C, Yang Y, Hojnowski L, Cherny R. Metastasis of osteosarcoma to soft tissue. A case report. J Bone Joint Surg Am. 2000;82(11):1634–8.CrossRef
20.
go back to reference Yamada K, Yatabe Y, Sugiura H. Osteosarcoma with skeletal muscle metastasis. Arch Orthop Trauma Surg. 2008;128(7):695–9.CrossRef Yamada K, Yatabe Y, Sugiura H. Osteosarcoma with skeletal muscle metastasis. Arch Orthop Trauma Surg. 2008;128(7):695–9.CrossRef
21.
go back to reference Xie L, Xu J, Sun X, Tang X, Yan T, Yang R, Guo W. Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial. Oncologist. 2019;24(7):e542–50.CrossRef Xie L, Xu J, Sun X, Tang X, Yan T, Yang R, Guo W. Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial. Oncologist. 2019;24(7):e542–50.CrossRef
22.
go back to reference Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy. Nat Rev Endocrinol. 2017;13(8):480–91.CrossRef Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy. Nat Rev Endocrinol. 2017;13(8):480–91.CrossRef
23.
go back to reference Arora RS, Kontopantelis E, Alston RD, Eden TO, Geraci M, Birch JM. Relationship between height at diagnosis and bone tumours in young people: a meta-analysis. Cancer Causes Control. 2011;22(5):681–8.CrossRef Arora RS, Kontopantelis E, Alston RD, Eden TO, Geraci M, Birch JM. Relationship between height at diagnosis and bone tumours in young people: a meta-analysis. Cancer Causes Control. 2011;22(5):681–8.CrossRef
24.
go back to reference Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer. 2012;118(5):1387–96.CrossRef Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer. 2012;118(5):1387–96.CrossRef
25.
go back to reference Vlachos A, Rosenberg PS, Atsidaftos E, Kang J, Onel K, Sharaf RN, Alter BP, Lipton JM. Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia. Blood. 2018;132(20):2205–8.CrossRef Vlachos A, Rosenberg PS, Atsidaftos E, Kang J, Onel K, Sharaf RN, Alter BP, Lipton JM. Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia. Blood. 2018;132(20):2205–8.CrossRef
26.
go back to reference Maciaszek JL, Oak N, Chen W, Hamilton KV, McGee RB, Nuccio R, Mostafavi R, Hines-Dowell S, Harrison L, Taylor L, et al. Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma. Cold Spring Harb Mol Case Stud. 2019;5(5):a004218.CrossRef Maciaszek JL, Oak N, Chen W, Hamilton KV, McGee RB, Nuccio R, Mostafavi R, Hines-Dowell S, Harrison L, Taylor L, et al. Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma. Cold Spring Harb Mol Case Stud. 2019;5(5):a004218.CrossRef
27.
go back to reference Chu WK, Hickson ID. RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer. 2009;9(9):644–54.CrossRef Chu WK, Hickson ID. RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer. 2009;9(9):644–54.CrossRef
28.
go back to reference Masliah-Planchon J, Lévy D, Héron D, Giuliano F, Badens C, Fréneaux P, Galmiche L, Guinebretierre JM, Cellier C, Waterfall JJ, et al. Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients. Eur J Hum Genet. 2018;26(8):1217–21.CrossRef Masliah-Planchon J, Lévy D, Héron D, Giuliano F, Badens C, Fréneaux P, Galmiche L, Guinebretierre JM, Cellier C, Waterfall JJ, et al. Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients. Eur J Hum Genet. 2018;26(8):1217–21.CrossRef
29.
go back to reference Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015;373(24):2336–46.CrossRef Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015;373(24):2336–46.CrossRef
30.
go back to reference Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, et al. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol. 2016;17(9):1261–71.CrossRef Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, et al. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol. 2016;17(9):1261–71.CrossRef
31.
go back to reference Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, Gianferante M, Spector LG, Morton LM, Karyadi D, et al. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA Oncol. 2020;6(5):724–34.CrossRef Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, Gianferante M, Spector LG, Morton LM, Karyadi D, et al. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA Oncol. 2020;6(5):724–34.CrossRef
32.
go back to reference Takita J. The role of anaplastic lymphoma kinase in pediatric cancers. Cancer Sci. 2017;108(10):1913–20.CrossRef Takita J. The role of anaplastic lymphoma kinase in pediatric cancers. Cancer Sci. 2017;108(10):1913–20.CrossRef
33.
go back to reference Yoshida A, Shibata T, Wakai S, Ushiku T, Tsuta K, Fukayama M, Makimoto A, Furuta K, Tsuda H. Anaplastic lymphoma kinase status in rhabdomyosarcomas. Mod Pathol. 2013;26(6):772–81.CrossRef Yoshida A, Shibata T, Wakai S, Ushiku T, Tsuta K, Fukayama M, Makimoto A, Furuta K, Tsuda H. Anaplastic lymphoma kinase status in rhabdomyosarcomas. Mod Pathol. 2013;26(6):772–81.CrossRef
34.
go back to reference Mossé YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008;455(7215):930–5.CrossRef Mossé YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008;455(7215):930–5.CrossRef
35.
go back to reference Ishibashi Y, Miyoshi H, Hiraoka K, Arakawa F, Haraguchi T, Nakashima S, Hashiguchi T, Shoda T, Hamada T, Okawa T, et al. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis. Oncol Rep. 2015;33(4):1667–74.CrossRef Ishibashi Y, Miyoshi H, Hiraoka K, Arakawa F, Haraguchi T, Nakashima S, Hashiguchi T, Shoda T, Hamada T, Okawa T, et al. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis. Oncol Rep. 2015;33(4):1667–74.CrossRef
36.
go back to reference Xu BS, Chen HY, Que Y, Xiao W, Zeng MS, Zhang X. ALK(ATI) interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma. Oncogene. 2020;39(1):151–63.CrossRef Xu BS, Chen HY, Que Y, Xiao W, Zeng MS, Zhang X. ALK(ATI) interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma. Oncogene. 2020;39(1):151–63.CrossRef
37.
go back to reference Fleuren EDG, Vlenterie M, van der Graaf WTA, Hillebrandt-Roeffen MHS, Blackburn J, Ma X, Chan H, Magias MC, van Erp A, van Houdt L, et al. Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes. Cancer Res. 2017;77(16):4279–92.CrossRef Fleuren EDG, Vlenterie M, van der Graaf WTA, Hillebrandt-Roeffen MHS, Blackburn J, Ma X, Chan H, Magias MC, van Erp A, van Houdt L, et al. Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes. Cancer Res. 2017;77(16):4279–92.CrossRef
38.
go back to reference Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS, et al. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A. 2014;111(51):E5564-5573.CrossRef Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS, et al. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A. 2014;111(51):E5564-5573.CrossRef
39.
go back to reference Reimann E, Kõks S, Ho XD, Maasalu K, Märtson A. Whole exome sequencing of a single osteosarcoma case–integrative analysis with whole transcriptome RNA-seq data. Hum Genomics. 2014;8(1):20.PubMedPubMedCentral Reimann E, Kõks S, Ho XD, Maasalu K, Märtson A. Whole exome sequencing of a single osteosarcoma case–integrative analysis with whole transcriptome RNA-seq data. Hum Genomics. 2014;8(1):20.PubMedPubMedCentral
40.
go back to reference Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363(18):1727–33.CrossRef Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363(18):1727–33.CrossRef
41.
go back to reference Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, et al. Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med. 2014;370(13):1189–97.CrossRef Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, et al. Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med. 2014;370(13):1189–97.CrossRef
42.
go back to reference Mossé YP, Voss SD, Lim MS, Rolland D, Minard CG, Fox E, Adamson P, Wilner K, Blaney SM, Weigel BJ. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. J Clin Oncol. 2017;35(28):3215–21.CrossRef Mossé YP, Voss SD, Lim MS, Rolland D, Minard CG, Fox E, Adamson P, Wilner K, Blaney SM, Weigel BJ. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. J Clin Oncol. 2017;35(28):3215–21.CrossRef
43.
go back to reference Jiao XD, Liu K, Xu M, Yu G, Liu D, Huang T, Qin BD, Liu M, Wu Y, Ling Y, et al. Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis. Oncologist. 2020;26(4):e524–9.CrossRef Jiao XD, Liu K, Xu M, Yu G, Liu D, Huang T, Qin BD, Liu M, Wu Y, Ling Y, et al. Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis. Oncologist. 2020;26(4):e524–9.CrossRef
Metadata
Title
Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis
Authors
Chuanxi Zheng
Yitian Wang
Yi Luo
Zongguo Pang
Yong Zhou
Li Min
Chongqi Tu
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-022-05020-6

Other articles of this Issue 1/2022

BMC Musculoskeletal Disorders 1/2022 Go to the issue